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Boston, Mass
Objective: Lower extremity amputation is often performed in patients where both lower extremities are at risk due to
peripheral arterial disease or diabetes, yet the proportion of patients who progress to amputation of their contralateral
limb is not well deﬁned. We sought to determine the rate of subsequent amputation on both the ipsilateral and
contralateral lower extremities following initial amputation.
Methods:We conducted a retrospective review of all patients undergoing lower extremity amputation (exclusive of trauma
or tumor) at our institution from 1998 to 2010. We used International Classiﬁcation of Diseases-Ninth Revision codes to
identify patients and procedures as well as comorbidities. Outcomes included the proportion of patients at 1 and 5 years
undergoing contralateral and ipsilateral major and minor amputation stratiﬁed by initial major vs minor amputation. Cox
proportional hazards regression analysis was performed to determine predictors of major contralateral amputation.
Results:We identiﬁed 1715 patients. Mean age was 67.2 years, 63% were male, 77% were diabetic, and 34% underwent an
initial major amputation. After major amputation, 5.7% and 11.5% have a contralateral major amputation at 1 and 5
years, respectively. After minor amputation, 3.2% and 8.4% have a contralateral major amputation at 1 and 5 years while
10.5% and 14.2% have an ipsilateral major amputation at 1 and 5 years, respectively. Cox proportional hazards regression
analysis revealed end-stage renal disease (hazard ratio [HR], 3.9; 95% conﬁdence interval [CI], 2.3-6.5), chronic renal
insufﬁciency (HR, 2.2; 95% CI, 1.5-3.3), atherosclerosis without diabetic neuropathy (HR, 2.9; 95% CI, 1.5-5.7),
atherosclerosis with diabetic neuropathy (HR, 9.1; 95% CI, 3.7-22.5), and initial major amputation (HR, 1.8; 95% CI,
1.3-2.6) were independently predictive of subsequent contralateral major amputation.
Conclusions: Rates of contralateral limb amputation are high and predicted by renal disease, atherosclerosis, and
atherosclerosis with diabetic neuropathy. Physicians and patients should be alert to the high risk of subsequent ampu-
tation in the contralateral leg. All patients, but particularly those at increased risk, should undergo close surveillance and
counseling to help prevent subsequent amputations in their contralateral lower extremity. (J Vasc Surg 2013;58:1571-7.)Lower extremity amputation is often performed due to
consequences of peripheral arterial disease (PAD), a problem
which affects an estimated 5 million adults over the age
of 40.1 Approximately 60,000 major amputations are
performed each year in the United States.2 Risk factors
for PAD, such as increased age, smoking, male gender,
diabetes, hypertension, and hyperlipidemia, have been well
documented.3Diabetes iswidely cited as a risk factor for lower
extremity amputation.2,4,5 Other identiﬁed risk factors
for lower extremity amputation include hypertension, renalthe Department of Surgery, Division of Vascular and Endovascular
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://dx.doi.org/10.1016/j.jvs.2013.06.055insufﬁciency,2 non-white race,6 low socioeconomic status,7
male gender, and hypertriglyceridemia.8
Factors that place patients at higher risk for PAD as
well as lower extremity amputation affect not just the
limb undergoing the amputation but also the patient
systemically. Prior studies have focused on the primary
limb undergoing amputation. The fate of the contralateral
limb, however, has not been well described in the litera-
ture. Published rates of amputation in the contralateral
limb vary from 2.2% to 19.8% over periods from 12 months
to 10 years.9-11 Because amputation has implications on
both mobility and functionality,12 we feel it is important
to further investigate factors that may lead to contralateral
amputations.
METHODS
Overview. We performed a retrospective review of all
patients undergoing a ﬁrst time lower extremity amputation
at our institution from 1998 to 2010. Patients were identi-
ﬁed using the International Classiﬁcation of Diseases, Ninth
Edition (ICD-9) procedure codes for lower extremity ampu-
tation (84.10-84.19). Toe or transmetatarsal amputations
were considered minor (84.11-84.12) and amputations
through the ankle or above were considered major (84.13-
84.19). We then performed a thorough chart review of all
patients identiﬁed with ICD-9 codes to verify amputation1571
Table I. Demographics and comorbidities of the 1715
patients who underwent an initial lower extremity
amputation, stratiﬁed by level (minor vs major)
Minor (n ¼ 1140) Major (n ¼ 575) P value
Mean age 6
SD, years
66.6 6 13.5 68.5 6 13.4 <.01
Male 67.3% 55.0% <.001
Diabetic 73.6% 83.3% <.001
CRI 23.6% 22.3% .53
ESRD 7.5% 7.8% .84
Hypertension 64.2% 62.1% .39
Non-white race 32.5% 36.2% .12
CRI, Chronic renal insufﬁciency; ESRD, end-stage renal disease; SD,
standard deviation.
Table II. Demographics and comorbidities of patients
with no subsequent amputations compared with those
with a subsequent contralateral major amputation
No subsequent
amputation
(n ¼ 1156)
Contralateral major
amputation
(n ¼ 134) P value
Mean age 6
SD, years
67.6 6 13.5 65.9 6 12.7 .16
Male 66.0% 54.5% <.01
Diabetic 77.0% 88.1% <.001
CRI 19.6% 28.6% <.01
ESRD 6.0 % 17.9% <.001
Hypertension 62.4% 68.7% .32
Non-white race 34.9% 41.0% .01
CRI, Chronic renal insufﬁciency; ESRD, end-stage renal disease; SD,
standard deviation.
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1572 Glaser et al December 2013levels as well as the laterality of all amputations. Patients were
included in our analysis if their primary admission ICD-9
diagnosis code was related to nonhealing wounds with or
without PAD or ischemic rest pain. Those whose primary
admission ICD-9 diagnosis code was for trauma, tumor, or
orthopedic complications were excluded (Supplementary
Table I [online only] contains the complete list of ICD-9
diagnosis codes included and excluded in our analysis).
Admission ICD-9 diagnosis codes were used to determine
the presence of comorbidities (Supplementary Table II
[online only] contains a list of all ICD-9 codes used to
identify diabetes, chronic renal insufﬁciency [CRI], end-
stage renal disease [ESRD], and hypertension). This
method has been shown to be an accurate method of iden-
tifying those with diabetes,13 but the severity of diabetes and
insulin dependence was not speciﬁed. The speciﬁc set of
ICD-9 diagnosis codes used to identify patients with CRI,
while not able to provide the stage of disease, have been
shown tohave a positive predictive value greater than90% for
identifying those with chronic kidney disease.14 A hierar-
chical model was used and the presence of a dialysis ICD-9
code classiﬁes the patient as having ESRD whether or not
a CRI diagnosis code is present. Patients with diabetes were
stratiﬁed according the presence or absence of diagnosis
codes for diabetic neuropathy.Patients were stratiﬁed based on the level of their ﬁrst
amputation, either minor or major. Subsequent amputa-
tions were classiﬁed as ipsilateral or contralateral as
compared with the initial amputation and as major or
minor based on the level of amputation. If an initial ampu-
tation was performed to control sepsis, with a planned
subsequent amputation, the subsequent amputation was
not included in our analysis. Our primary outcome was
the rate of subsequent major amputations in the contralat-
eral leg. Secondary outcomes included the rate of other
subsequent amputations including contralateral minor,
ipsilateral minor, and ipsilateral major amputations. Chart
review determined the date of the patient’s last known
follow-up at our institution. The Social Security Death
Index was used to determine the date of death.
Statistical analysis. Preoperative characteristics are re-
ported as proportions of the sample and mean 6 standard
deviation. Categorical variables were analyzed using c2 and
the Fisher exact test where appropriate. Continuous
variables were compared using the Wilcoxon rank sum
test. Kaplan-Meier estimates were used to determine rates
of subsequent amputations. Cox proportional hazards
modeling was used to determine rates of subsequent con-
tralateral major amputations over time as well as to deter-
mine rates of contralateral major amputations in those
subgroups of patients at increased risk: (1) all patients
stratiﬁed based on the presence of diabetes; (2) all patients
stratiﬁed based on the presence of CRI; (3) all patients
stratiﬁed based on the presence of ESRD; and (4) diabetic
patients with and without CRI. Statistical signiﬁcance was
deﬁned as P < .05. All statistical analyses were performed
using STATA 12 software (StataCorp LP, College Station,
Tex). This study was approved by the Institutional Review
Board at Beth Israel Deaconess Medical Center.
RESULTS
We identiﬁed 1715 patients who underwent a lower
extremity amputation due to PAD at our institution: 575
underwent major amputations and 1140 underwent minor
amputations. Of the initial major amputations, below-knee
amputations were performed on 431 patients and initial
above-knee amputations were performed on 144 patients.
Sixty-three percent of all patients were male, and 77%
were diabetic. The average age was 67.2 years. Demo-
graphics stratiﬁed by the level of initial amputation are
shown in Table I. Patients who initially underwent major
amputations tended to be older and were more likely to
be diabetic when compared with those who initially under-
went minor amputations. While men made up the majority
of those undergoing both minor and major amputations,
a greater proportion of women underwent an initial major
amputation compared to men (40.8% vs 29.2%; P < .01).
The prevalence of hypertension, CRI, ESRD, and non-
white race was similar between those undergoing initial
minor vs initial major amputations.
Of the 1715 patients who underwent an initial ampu-
tation at our institution during the study period, 559
patients went on to have 729 subsequent amputations.
Table III. Patients with subsequent major amputation, stratiﬁed by level of initial amputation
Contralateral major Ipsilateral major
1 year, No. (%) 5 years, No. (%) 1 year, No. (%) 5 years, No. (%)
Initial minor amputation 36 (3.2) 70 (8.4) 112 (10.5) 138 (14.2)
Initial major amputation 35 (5.7) 52 (11.5) 38 (7.1) 41 (8.4)
Table IV. Patients with subsequent minor amputations, stratiﬁed by level of initial amputation
Contralateral minor Ipsilateral minor
1 year, No. (%) 5 years, No. (%) 1 year, No. (%) 5 years, No. (%)
Initial minor amputation 86 (7.0) 138 (15.0) 188 (14.2) 226 (19.9)
Initial major amputation 17 (4.0) 31 (9.0) NA NA
Fig 1. Kaplan-Meier survival curves depicting rates of contralateral
major amputation in all patients undergoing either an initial major
or initial minor amputation (P ¼ .03). Standard error is <10%
throughout both curves.
Table V. Predictors of contralateral major amputation
HR 95% CI P value
Female 1.3 0.9-1.9 .11
Non-white race 0.8 0.6-1.2 .27
CRI 2.2 1.5-3.3 <.001
ESRD 3.9 2.3-6.5 <.001
Diabetes without neuropathy 1.7 0.9-3.2 .13
Diabetic neuropathy 0.9 0.1-7.5 .91
Atherosclerosis without diabetic
neuropathy
2.9 1.5-5.7 <.01
Atherosclerosis with diabetic
neuropathy
9.1 3.7-22.5 <.001
Initial major amputation 1.8 1.3-2.6 <.01
Initial minor amputation 0.6 0.4-0.8 <.01
CI, Conﬁdence interval; CRI, chronic renal insufﬁciency; ESRD, end-stage
renal disease; HR, hazard ratio.
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amputations, 415 were on the ipsilateral limb, including
184 major amputations, and 314 were on the contralateral
limb, including 134 major amputations. A large proportion
of the initial population (1156 patients) did not undergo
a subsequent amputation. Characteristics of patients who
underwent a contralateral major amputation as well as
those who did not undergo any subsequent amputation
are shown in Table II. Compared with those who did
not undergo a subsequent amputation, patients who
underwent a major amputation on the contralateral limb
were more likely to be female, of nonwhite race, diabetic,
and have renal disease.
Subsequent amputations. Rates of subsequent ampu-
tations varied by the level of the initial amputation
(Table III). During follow-up, 11.5% of those under-
going an initial major amputation had a contralateral major
amputation by 5 years compared with 8.4% of thoseundergoing an initial minor amputation. Of those under-
going an initial major amputation, 8.4% had an ipsilateral
revision amputation or more proximal major amputation
by 5 years while 14.2% of those undergoing an initial minor
amputation had an ipsilateral major amputation. Table IV
lists the rates of subsequent minor amputations. Of those
undergoing an initial minor amputation, by 5 years, 15.0%
underwent a contralateral minor amputation, while 19.9%
had an additional subsequent ipsilateral minor amputation.
Nine percent of those undergoing an initial major ampu-
tation had a contralateral minor amputation by 5 years.
Fig 1 shows freedom from contralateral major amputation
based on the level of initial amputation.
Predictors of contralateral major amputation. Cox
regression analysis revealed several factors that were predic-
tive of a contralateral major amputation. ESRD (hazard
ratio [HR], 3.9; 95% conﬁdence interval [CI], 2.3-6.5),
CRI (HR, 2.2; 95% CI, 1.5-3.3), atherosclerosis without
diabetic neuropathy (HR, 2.9; 95% CI, 1.5-5.7), athero-
sclerosis with diabetic neuropathy (HR, 9.1; 95% CI,
3.7-22.5), and initial major amputation (HR, 1.6; 95%
CI, 1.3-2.6) were independently predictive of subsequent
Fig 2. Kaplan-Meier survival curves depicting rates of contralateral
major amputation in all patients with and without diabetes in (A)
those who underwent an initial major amputation (P ¼ .02) and
(B) those who underwent an initial minor amputation (P ¼ .13).
Standard error is <10% throughout both curves.
Fig 3. Kaplan-Meier survival curves depicting rates of contralateral
major amputation in all patients with and without chronic renal
insufﬁciency (CRI) in (A) those who underwent an initial major
amputation (P < .001) and (B) those who underwent an initial
minor amputation (P < .01). Standard error is <10% throughout
both curves.
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initial below-knee (HR, 1.3; 95% CI, 0.9-1.9) and above-
knee (HR, 1.6; 95% CI, 0.9-3.1) amputations were not
differentially associated with subsequent contralateral
major amputations.
For those undergoing an initial major amputation, dia-
betes was signiﬁcantly associated with subsequent contralat-
eral major amputations (HR, 2.8; 95% CI, 1.1-7.1; P¼ .02;
Fig 2, A). However, in those undergoing an initial minor
amputation, the risk of contralateral major amputation
between diabetics and nondiabetics was similar in magni-
tude and direction but did not reach statistical signi-
ﬁcance (HR, 1.8; 95% CI, 0.8-3.9; P ¼ .13; Fig 2, B).
Patients with CRI had higher rates of contralateral major
amputations than those without (HR, 2.7; 95% CI,
1.5-4.8; P < .001 for those undergoing initial major ampu-
tations; Fig 3,A; and HR, 2.0; 95% CI, 1.2-3.2; P< .01 for
those undergoing initial minor amputations; Fig 3, B).Patients with ESRD had higher rates of contralateral major
amputations than those without for those undergoing initial
major (HR, 3.2; 95% CI, 1.4-7.2; P< .01) and initial minor
(HR, 4.4; 95% CI, 2.5-7.9; P < .01) amputations, respec-
tively (Fig 4, A and B). Among diabetics, those with CRI
also had higher rates of contralateral major amputations
(HR, 2.5; 95% CI, 1.4-4.7; P < .01 and HR, 1.7; 95%
CI, 1.0-2.8; P ¼ .04) for initial major and initial minor
amputations, respectively.
Mortality. Kaplan-Meier estimates of mortality were
17.0%, 29.1%, and 49.0% at 1, 3, and 5 years after initial
minor amputations, and 19.2%, 48.7%, and 61.3% at 1,
3, and 5 years after initial major amputations (Fig 5).
DISCUSSION
Our analysis shows that 8.4% of those undergoing an
initial minor amputation and 11.5% of those undergoing
an initial major amputation will undergo a contralateral
major amputation within 5 years. Approximately 14% of
those undergoing an initial minor amputation will need
an ipsilateral major amputation within 5 years. ESRD,
Fig 4. Kaplan-Meier survival curves depicting rates of contralateral
major amputation in all patients with and without end-stage renal
disease (ESRD) in (A) those who underwent an initial major
amputation (P < .01; dotted line denotes where standard error
exceeds 10%) and (B) those who underwent an initial minor ampu-
tation (P < .001; standard error is <10% throughout the curve).
Fig 5. Kaplan-Meier survival curves depicting overall mortality in
those undergoing either an initial major or initial minor amputa-
tion (P < .001; standard error is <10% throughout the graph).
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and an initial major amputation all predict subsequent
contralateral major amputations.
Prior studies have evaluated subpopulations of patients,
such as studies of outcomes in diabetics only,8,15,16 and pop-
ulations that include vascular as well as oncologic and
trauma patients.17 Prior single-institution series that used
chart review and included the rates of subsequent amputa-
tions range in size from 87 to 277 patients undergoing
major lower extremity amputation5,12,15,18-20; most did
not examine the fates of those whose initial amputation
was minor. Variation in subsequent amputation rates
between those studies and ours may be accounted for by
the smaller number of patients in previous works. Studies
using data collected prior to the year 2000 show rates higher
than ours, with 15% to 53.3% of patients undergoing ampu-
tations needing a contralateral major amputation within 2 to
5 years.15,21,22 The number of amputations performed in
the United States has decreased in the last decade.23 The
same changes that have accounted for this have likelycontributed to the decrease in rates of contralateral major
amputation we have shown.
The risk factors revealed in our analysis are not
surprising. Diabetics are known to be at higher risk of lower
extremity amputation19 and are more likely to undergo
contralateral revascularizations after lower extremity bypass.24
A single-institution study of 258 patients also documented
that they are at greater risk of a second amputation on the
same or contralateral limb.5 Those with ESRD are also at
higher risk of lower extremity amputation, which is similar
to our ﬁnding that those with CRI or ESRD are at increased
risk of contralateral major amputation.19,25 Our study
further illustrates that those with diabetes and renal disease
are a population particularly at risk for limb loss. In our
study, the likelihood of progression to contralateral major
amputation increases between CRI and ESRD; this suggests
that as the severity of kidney disease worsens so does the
prognosis for the contralateral limb. Among diabetics, those
with renal disease fare poorly.
Prior work has shown that more men than women
undergo lower extremity amputation,4 but that women
are more likely than men to undergo above-knee as
compared with below-knee amputation.26 Our results are
similar, as the majority of the amputations performed at
our institution were in men. However, women were
more likely to have a major vs minor amputation compared
with men. We also found that women are more likely than
men to progress to a subsequent contralateral major ampu-
tation. There are many possible reasons as to why this
occurs. Women have been found to be more likely to
present with occlusions as well as multilevel disease as
compared with men, even when adjusted for age, smoking,
and diabetes.27 In a study of gender differences among all
lower extremity revascularization or amputation proce-
dures, women were shown to have lower rates of hospital-
ization for revascularization procedures but higher rates of
mortality after amputation, and women tended to present
at later stages of disease.28 Hormonal changes as women
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their male counterparts, which may lead to some of these
changes. Elucidating the reasons for their elevated risk in
this study and others necessitates further study, potentially
on both a basic science and clinical level.
Our survival rate is comparable to previously reported
estimates, suggesting that this patient cohort is comparable
to others in the literature.9,10,18,25 One study using Medi-
care data found survival rates at 1 year of 71% to 77% for
those undergoing minor amputations and 47% to 64% for
those undergoing major amputations.9 This corresponds
with our ﬁnding that minor amputees have better survival
initially than those undergoing major amputation.
As with all single-institution studies, our data and
conclusions may not extend to all patients. However, chart
review allowed us to deﬁnitively state whether a subsequent
amputation was ipsilateral or contralateral; this is not the
case in studies of large databases such as Medicare or the
Nationwide Inpatient Sample where laterality has to be
inferred. The large sample included in our study, over
1700 patients, makes it more likely that our results are
applicable to other populations. Our institution is located
in a major metropolitan area; we cannot account for ampu-
tations that patients may have had elsewhere. Additionally,
our institution is well known for aggressive revasculariza-
tion for limb salvage.29-32 Rates may be higher at centers
where this is not the case; variation in this area warrants
further study.
We noted a high rate of diabetes in our study popula-
tion (77% of patients). This is consistent with other
studies.4,5,10,20,33 Additionally, the study is biased toward
patients whose operations occurred earlier in our study
period due to a longer follow-up time; our data may under-
estimate the effects of changes in practice over the 12-year
period during which it was collected. We also do not have
presenting clinical symptoms and data on prior or simulta-
neous revascularization, which may affect initial treatment
decisions and risk for subsequent amputations. We do
not have ankle brachial index data for our patients, which
prevents us from determining the severity of PAD, and
we did not account for the level of disease when examining
rates of amputation. This prevents us from stratifying
patients based on the extent or severity of their PAD, but
we feel that none of these limitations signiﬁcantly detracts
from our overall conclusions.
In this study, we have shown that the rate of a contra-
lateral major amputation is 8.4% and 11.5% within 5 years
for all patients undergoing initial minor and major amputa-
tions, respectively. Speciﬁcally, those with renal disease,
atherosclerosis, and diabetic neuropathy are at even greater
risk. All patients, but especially these high-risk groups,
should have close surveillance of their contralateral limb.AUTHOR CONTRIBUTIONS
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Supplementary Table I (online only). ICD-9 diagnosis
codes used to identify patients with amputations due to
non-healing wounds with or without peripheral arterial
disease or ischemic rest pain
Diagnosis ICD-9 codes
Included diagnoses
Atherosclerosis 440.x
Diabetes 250.x
Complications of vascular
procedures
996.1, 996.62, 996.74, 997.6
Osteomyelitis 730.x
Gangrene and sepsis 038.x, 785.4
Chronic ulcers 707.1
Cellulitis 681.1, 682.6-7
Peripheral vascular disease 443.89-90
Open wounds 892.1, 893.0-1
Excluded diagnoses
Neoplasms 171-3.x, 198.x, 215.x
Fractures and dislocations 800-839.x; 733.x
Trauma 858.3-8, 928.x, 906.4
Orthopedic complications 996.4, 996.66-7
Acquired deformities 736.x
Frostbite 991.2
Necrotizing fasciitis 728.86
Pelvic pyogenic arthritis 711.05
ICD-9, International Classiﬁcation of Diseases, Ninth Edition.
Supplementary Table II (online only). ICD-9
diagnosis codes used to identify diabetes, CRI, ESRD,
and hypertension
Comorbidity Codes
Diabetes
250.0-9 Diabetes mellitus
357.2 Polyneuropathy in diabetes
362.0 Diabetic retinopathy
V58.67 Long-term insulin use
V45.85 Insulin pump status
249.00 Secondary diabetes mellitus
CRI
582.x Chronic glomerulonephritis
583.x Nephritis and nephropathy
585.0-5, 9 Chronic kidney disease
586 Renal failure, unspeciﬁed
587 Renal sclerosis, unspeciﬁed
403 Hypertensive chronic kidney disease
404 Hypertensive heart and chronic
kidney disease
250.4 Diabetes with renal complications
ESRD
585.6 Chronic kidney disease, stage V
requiring dialysis
V56.8 Other dialysis status (peritoneal)
V45.1 Renal dialysis status
Hypertension
401.1 Essential hypertension
402.91 Hypertensive disease with
congestive heart failure
403.91 Hypertensive chronic kidney disease
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1577.e1 Glaser et al December 2013437.2 Hypertensive encephalopathyCRI, Chronic renal insufﬁciency; ESRD, end-stage renal disease; ICD-9,
International Classiﬁcation of Diseases, Ninth Edition.
